PremiumRatingsClinigence Holdings’ Strong Financial Performance and Strategic Successes Drive Buy Rating Nutex Health reports Q1 EPS $2.56 vs. (8c) last year Nutex Health up 10% afterhours at $138 per share following Q1 results PremiumCompany AnnouncementsNutex Health Inc. Reports Strong 2024 Financial Turnaround Nutex Health Inc: Strong Financial Performance and Strategic Initiatives Justify Buy Rating Closing Bell Movers: PVH jumps 15% on earnings and guidance PremiumCompany AnnouncementsNutex Health Reports Strong Revenue Growth in Q3 2024 Nutex Health price target raised to $50 from $45 at Maxim Nutex Health price target raised to $60 from $45 at Benchmark 
